GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Foyou Pharma Co Ltd (SHSE:601089) » Definitions » EV-to-Revenue

Beijing Foyou Pharma Co (SHSE:601089) EV-to-Revenue : 1.35 (As of Jun. 24, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Beijing Foyou Pharma Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Beijing Foyou Pharma Co's enterprise value is ¥4,493 Mil. Beijing Foyou Pharma Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥3,323 Mil. Therefore, Beijing Foyou Pharma Co's EV-to-Revenue for today is 1.35.

The historical rank and industry rank for Beijing Foyou Pharma Co's EV-to-Revenue or its related term are showing as below:

SHSE:601089' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.18   Med: 1.67   Max: 1.96
Current: 1.35

During the past 6 years, the highest EV-to-Revenue of Beijing Foyou Pharma Co was 1.96. The lowest was 1.18. And the median was 1.67.

SHSE:601089's EV-to-Revenue is ranked better than
69.84% of 1018 companies
in the Drug Manufacturers industry
Industry Median: 2.23 vs SHSE:601089: 1.35

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-24), Beijing Foyou Pharma Co's stock price is ¥13.70. Beijing Foyou Pharma Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥6.94. Therefore, Beijing Foyou Pharma Co's PS Ratio for today is 1.97.


Beijing Foyou Pharma Co EV-to-Revenue Historical Data

The historical data trend for Beijing Foyou Pharma Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Foyou Pharma Co EV-to-Revenue Chart

Beijing Foyou Pharma Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial - - - 1.53 1.76

Beijing Foyou Pharma Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.54 1.65 1.80 1.76 1.49

Competitive Comparison of Beijing Foyou Pharma Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Foyou Pharma Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Foyou Pharma Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing Foyou Pharma Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Beijing Foyou Pharma Co's EV-to-Revenue falls into.



Beijing Foyou Pharma Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Beijing Foyou Pharma Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=4492.540/3323.182
=1.35

Beijing Foyou Pharma Co's current Enterprise Value is ¥4,493 Mil.
Beijing Foyou Pharma Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3,323 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Foyou Pharma Co  (SHSE:601089) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Beijing Foyou Pharma Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=13.70/6.938
=1.97

Beijing Foyou Pharma Co's share price for today is ¥13.70.
Beijing Foyou Pharma Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥6.94.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Foyou Pharma Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Beijing Foyou Pharma Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Foyou Pharma Co (SHSE:601089) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Guangyuan East Street, Tongzhou Industrial Development Zone, Tongzhou District, Beijing, CHN, 101113
Beijing Winsunny Pharmaceutical Co Ltd in the research and development, production and sales of pharmaceutical preparations and medical devices.

Beijing Foyou Pharma Co (SHSE:601089) Headlines

No Headlines